Statement Of Cash Flows [Abstract]

BioPorto - Filing #1343302

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
61,799,000 DKK
57,768,000 DKK
Cash flows from (used in) operating activities
55,456,000 DKK
52,485,000 DKK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
39,000 DKK
407,000 DKK
Purchase of intangible assets, classified as investing activities
- DKK
64,000 DKK
Cash flows from (used in) investing activities
277,000 DKK
503,000 DKK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
3,738,000 DKK
3,737,000 DKK
Cash flows from (used in) financing activities
40,790,000 DKK
88,699,000 DKK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
14,943,000 DKK
35,711,000 DKK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
447,000 DKK
558,000 DKK
Cash and cash equivalents
66,402,000 DKK
81,792,000 DKK
45,523,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.